Hjem › Brystkreft › Texas › Lewisville
Kliniske studier for Brystkreft i Lewisville, TX
5 studier for Brystkreft søker deltakere på steder i og rundt Lewisville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Texas Oncology - Northeast Texas ( Site 8002), Flower Mound · 6 mi unna
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruttererFase 2/3
- Texas Oncology - Northeast Texas, Flower Mound · 6 mi unna
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Texas Oncology-Northeast Texas, Lewisville
- Texas Oncology-Northeast Texas, Flower Mound · 6 mi unna
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
RekruttererFase 1
- Texas Oncology - Flower Mound, Flower Mound · 6 mi unna
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruttererObservasjonsstudie
- Texas Oncology - Flower Mound, Flower Mound · 6 mi unna
- Texas Oncology - Grapevine, Grapevine · 9 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Lewisville
- Ulcerøs kolitt10 studier
- Crohns sykdom9 studier
- Type 2-diabetes5 studier
- Spinal muskelatrofi4 studier
- Inflammatorisk tarmsykdom4 studier
- Fordøyelsessykdommer4 studier
- Makuladegenerasjon3 studier
- Kardiovaskulær sykdom3 studier
- Kolorektal kreft3 studier
- Geografisk atrofi3 studier
- Tripelnegativ brystkreft3 studier
- Lungesykdommer3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.